Cargando…
Flea and tick treatment satisfaction, preference, and adherence of US cat owners prescribed topical fluralaner (Bravecto(®) Topical Solution for Cats)
BACKGROUND: Fluralaner is a novel isoxazoline compound and the only systemically distributed ectoparasiticide approved in the United States for redosing at up to 12-week intervals for flea and tick control in cats. Other feline ectoparasiticides, including other systemic isoxazolines, are approved f...
Autores principales: | Lavan, Robert, Normile, Dorothy, Armstrong, Rob, Vaala, Wendy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of Veterinary Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057215/ https://www.ncbi.nlm.nih.gov/pubmed/33898287 http://dx.doi.org/10.4314/ovj.v11i1.12 |
Ejemplares similares
-
Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the US, UK, or France who treated their cats with transdermal fluralaner
por: Lavan, Robert Philip, et al.
Publicado: (2021) -
Flea and tick treatment satisfaction, preference, and adherence of dog owners in the United States, United Kingdom, and Australia who treated their dog with fluralaner
por: Lavan, Robert, et al.
Publicado: (2020) -
Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA
por: Lavan, Robert, et al.
Publicado: (2020) -
Dog owner flea/tick medication purchases in the USA
por: Lavan, Robert, et al.
Publicado: (2018) -
Efficacy of two topical fluralaner formulations (Bravecto®; Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats
por: Petersen, Melissa, et al.
Publicado: (2023)